No Data
Jefferies Initiates ATyr Pharma(ATYR.US) With Buy Rating, Announces Target Price $9
Jefferies analyst Roger Song initiates coverage on $aTyr Pharma(ATYR.US)$ with a buy rating, and sets the target price at $9.According to TipRanks data, the analyst has a success rate of 31.9% and a
Express News | ATyr Pharma Inc : Jefferies Initiates With Buy Rating; Price Target $9
ATyr Pharma to Participate in September Investor Conferences
Is ATyr Pharma (NASDAQ:ATYR) In A Good Position To Invest In Growth?
Buy Rating on ATyr Pharma Anchored by Upcoming Clinical Trials and Strong Financials
ATyr Pharma Price Target Maintained With a $16.00/Share by RBC Capital
No Data
No Data